{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:01:58Z","timestamp":1791594118184,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.eplepsyres.2014.01.021","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T07:01:22Z","timestamp":1391324482000},"page":"717-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Topiramate monotherapy use in women with and without epilepsy: Pregnancy and neonatal outcomes"],"prefix":"10.1016","volume":"108","author":[{"given":"Ruby","family":"Castilla-Puentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert F.","family":"Kwarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.021_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/epi.12001","article-title":"Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero","volume":"54","author":"Campbell","year":"2013","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.eplepsyres.2014.01.021_bib0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1526-4610.2012.02190.x","article-title":"Utilization of topiramate during pregnancy and risk of birth defects","volume":"52","author":"Green","year":"2012","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.021_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidencebased review): teratogenesis and perinatal outcomes","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.eplepsyres.2014.01.021_bib0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.01.021_bib0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1586\/ern.10.57","article-title":"Teratogenic effects of antiepileptic drugs","volume":"10","author":"Hill","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0030","unstructured":"http:\/\/onlinelibrary.wiley.com. Birth Defects Research Part A: Clinical and Molecular Teratology. 2007; 79(2) [Appendix B: Conditions Not Considered to be Major Congenital Defects, pp. 178\u2013179]), http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.20353\/full."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0035","unstructured":"http:\/\/www.cdc.gov. Birth defects and genetic diseases branch 6-digit code for reportable congenital anomalies: [Exclusion List, pp. 93\u2013105]: http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/documents\/MACDPcode0807.pdf (accessed 10.01.13)."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0040","unstructured":"http:\/\/www.cdc.gov (accessed 18.03.13). Centers for disease control and prevention from http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/index.html."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0045","unstructured":"http:\/\/www.eurocat-network.eu (2005). EUROCAT Guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies. Retrieved 15 September 2011 from http:\/\/www.eurocat-network.eu\/content\/EUROCAT-Guide-1.3.pdf."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0050","unstructured":"http:\/\/www.kemh.health.wa.gov.au, 2011, W.A.R.o.D.A.e.l.r.F.A.S. (2011). Western Australian Register of Developmental Anomalies: exclusion list (revised February 2011). Retrieved 15 September 2011 from http:\/\/www.kemh.health.wa.gov.au\/services\/register_developmental_anomalies\/documents\/exclusionList.pdf."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0055","unstructured":"http:\/\/www.nbdpn.org (2011). NBDPN guidance for conducting birth defect surveillance appendix 3.3: Examples of Conditions Considered to Be Minor Anomalies. Retrieved 15 September 2011, from http:\/\/www.nbdpn.org\/docs\/appendix3-3.pdf."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0060","series-title":"First North American Regional Epilepsy Congress: 60th Annual Meeting of the American Epilepsy Society","article-title":"Pregnancy outcomes in topiramate-treated women","author":"Kwarta","year":"2006"},{"issue":"14","key":"10.1016\/j.eplepsyres.2014.01.021_bib0065","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1212\/01.wnl.0000316199.92256.af","article-title":"Pregnancy registries in epilepsy: a consensus statement on health outcomes","volume":"71","author":"Meador","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.021_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.01.021_bib0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001362","article-title":"Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies","volume":"2","author":"Neyarapally","year":"2012","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.01.021_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res. Part A: Clin. Mol. Teratol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.01.021_bib0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.021_bib0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1684\/j.1950-6945.2004.tb00053.x","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.01.021_bib0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.seizure.2007.11.016","article-title":"Teratogenic effects of antiepileptic drugs","volume":"17","author":"Tomson","year":"2008","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.eplepsyres.2014.01.021_bib0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2014.01.021_bib0105","unstructured":"TOPAMAX\u00ae (Jan 2012 [revised]). Prescibing information."},{"issue":"9","key":"10.1016\/j.eplepsyres.2014.01.021_bib0110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.seizure.2010.07.019","article-title":"Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register","volume":"19","author":"Vajda","year":"2010","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.01.021_bib0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1167.2012.03625.x","article-title":"Teratogenesis in repeated pregnancies in antiepileptic drug-treated women","volume":"54","author":"Vajda","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.01.021_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1528-1157.2003.t01-1-44703.x-i1","article-title":"Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation","volume":"44","author":"Yerby","year":"2003","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:29:37Z","timestamp":1760275777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0920121114000369"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.021","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate monotherapy use in women with and without epilepsy: Pregnancy and neonatal outcomes","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}